Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene therapy: a primer for neurosurgeons.

E Antonio Chiocca1

  • 1Molecular Neuro-oncology Laboratory, Neurosurgery Service, Massachusetts General Hospital, Brain Tumor Center, Boston, Massachusetts 02114, USA. Chiocca@helix.mgh.harvard.edu

Neurosurgery
|August 20, 2003
PubMed
Summary

Gene therapy uses viral vectors for efficient gene transfer in neurosurgery, showing relative safety for glioma, Parkinson's disease, and cerebral ischemia treatments. Continued research is vital for optimizing effectiveness and understanding potential toxicities in neurological disease therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

Neurosurgical Endovascular Credentialing in Europe and the United Kingdom for the "Complete" Neurovascular Surgeon: The Time has Come.

Neurosurgery·2026
Same author

IDH1-R132H enhances oncolytic HSV-1 therapy by facilitating viral entry and immune activation in glioma.

Nature communications·2026
Same author

Publisher Correction: Tumor transcriptional state predicts survival in immune-checkpoint-blockade-treated glioblastoma.

Nature cancer·2026
Same author

Tumor transcriptional state predicts survival in immune-checkpoint-blockade-treated glioblastoma.

Nature cancer·2026
Same author

Treatment Effect Reanalysis of the Randomized Individual Screening Trial of Innovative Glioblastoma Therapy in Newly Diagnosed Glioblastoma With External Control Data.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Oncolytic viruses and cytokine-based gene therapies reprogram the tumor microenvironment.

Nature cancer·2026

Area of Science:

  • Neurosurgery
  • Gene Therapy
  • Neurology

Background:

  • Gene therapy offers therapeutic gene transfer into cells.
  • Viral vectors are the most efficient gene delivery method.
  • Neurosurgical applications are expanding.

Purpose of the Study:

  • To review preclinical and clinical gene therapy applications in neurosurgery.
  • To assess the safety and efficacy of gene therapy in neurological diseases.
  • To highlight areas for future research in neurosurgical gene therapy.

Main Methods:

  • Review of preclinical and clinical studies.
  • Focus on glioma therapy, spinal neurosurgery, and neuroprotection.
  • Analysis of safety data from neurosurgical trials.

Related Experiment Videos

Main Results:

  • Gene therapy has shown promise in preclinical and clinical neurosurgical applications.
  • Therapies in neurosurgery have generally been safe.
  • Specific applications include glioma, Parkinson's disease, and cerebral ischemia.

Conclusions:

  • Gene therapy is a viable approach for neurological diseases treated neurosurgically.
  • While generally safe, potential toxicities require further investigation.
  • Continued research is crucial for developing effective neurosurgical gene therapies.